GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Cash Flow from Others

MLEC (Moolec Science) Cash Flow from Others : $-0.99 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Cash Flow from Others?

Moolec Science's cash flow from others for the three months ended in Jun. 2024 was $0.35 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.99 Mil.


Moolec Science Cash Flow from Others Historical Data

The historical data trend for Moolec Science's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science Cash Flow from Others Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Cash Flow from Others
- 0.87 -1.14 -0.99

Moolec Science Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.47 -0.95 0.36 -0.75 0.35

Moolec Science Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.99 Mil.

Moolec Science Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Moolec Science's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Moolec Science Business Description

Traded in Other Exchanges
N/A
Address
17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.